Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Solasto Corp. ( (JP:6197) ) has provided an announcement.
Solasto Corporation announced a stock buy-back plan as part of its Medium-term Business Plan for FY2025–2029, aiming to improve capital efficiency and enhance shareholder returns. The company plans to repurchase up to 4.8% of its outstanding common stock, with a total aggregate repurchase amount of up to 1.4 billion yen, through market purchases on the Tokyo Stock Exchange between August 13, 2025, and May 31, 2026.
The most recent analyst rating on (JP:6197) stock is a Hold with a Yen550.00 price target. To see the full list of analyst forecasts on Solasto Corp. stock, see the JP:6197 Stock Forecast page.
More about Solasto Corp.
Solasto Corporation operates in the healthcare and medical services industry, focusing on providing comprehensive healthcare management solutions. The company is known for its services in medical administration, home care, and other related healthcare services, primarily targeting the Japanese market.
Average Trading Volume: 274,561
Technical Sentiment Signal: Sell
Current Market Cap: Yen42.25B
See more insights into 6197 stock on TipRanks’ Stock Analysis page.